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A B S T R A C T
This is the protocol for a review and there is no abstract. The objectives are as follows:
To assess the impact of wound care teams on preventing and treating pressure ulcers in people of any age, nursed in any setting.
B A C K G R O U N D
Description of the condition
A pressure ulcer is defined as a localised injury to the skin or un-
derlying tissue, or both, usually over a bony prominence, as a re-
sult of pressure, or pressure in combination with shear. A number
of contributing or confounding factors are also associated with
pressure ulcers, the significance of which have yet to be elucidated
(EPUAP/NPUAP 2009). Pressure ulcers are commonly classified
according to the depth of tissue damage, ranging fromnon-blanch-
ing erythema of intact skin (tissue redness that does not turn white
when pressed) to full-scale tissue destruction (EPUAP/NPUAP
2009).
A large number of risk factors may contribute to pressure ulcer
development (Moore 2008), and in keeping with the EPUAP/
NPUAP 2009 guidance, Coleman 2013 argues that a complex
interplay of these factors increases the probability of pressure ulcer
development. There are three primary risk factors of particular
significance, namely; mobility and activity; impaired perfusion
(circulation problems, possibly due to diabetes); and fragile skin
or existing or previous pressure ulcers (Coleman 2013). These risk
factors mean that certain populations, such as the very old and
those with an inability to reposition themselves freely, are at greater
risk of developing pressure ulcers (Moore 2012).
’Prevalence’ refers to the number of people with a pressure ulcer at
a point in time, or during a specific time period, while ’incidence’
concerns the rate at which new pressure ulcers develop in a defined
population in a specific time period (Beaglehole 1993). Preva-
lence and incidence studies indicate that pressure ulcers are com-
mon. Indeed, prevalence rates range from0.38%to53.2% (Capon
2007; Igarashi 2013; Keelaghan 2008; Kwong 2011; Lahmann
2006; Moore 2012; Moore 2013b; Stevenson 2013; Tubaishat
2010; Vanderwee 2007), and incidence rates vary from 1.9% to
71.6% across Europe, Japan, China, the Middle East, the United
States of America (USA), Australia and Canada (Defloor 2005;
Igarashi 2013; Jolley 2004; Kwong 2011; Moore 2011; Moore
2013b; Scott 2006). Mean prevalence has been reported as being
20.9% within the acute-care setting, and 11.7% within the long-
stay setting; among hospice patients the mean figure is reported
to be 35.7%, but drops to 0.04% to 4% for those nursed in the
community (Moore 2013b). Incidence figures among the differ-
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ent care settings are similar to prevalence figures. For example,
mean incidence of pressure ulcers in the acute-care setting has been
reported as being 18% and for the long-stay setting the figure is
6.6%. There is little information available about pressure ulcer
incidence within the community-care setting (Moore 2013b).
The impact of pressure ulcers on the individual is profound, span-
ning the physical, emotional and social domains of life (Gorecki
2009). This impact is largely influenced by factors related to the
individual themselves, the healthcare professional and the envi-
ronment of care delivery (Gorecki 2012). Fundamentally, those
living with pressure ulcers experience significant anxieties that re-
late to their experiences of the ulcer, for example, the presence of
unrelieved intractable pain, in addition to challenges to their abil-
ity to cope with the demands that treatments impose upon them
(Gorecki 2012).
From a European perspective, pressure ulcer management absorbs
between 4% and 5% of the annual healthcare budget, with nurse
or healthcare-assistant time accounting for up to 90% of the over-
all costs (Posnett 2009). In the USA, pressure ulcers cost between
USD 9.1 billion to USD 11.6 billion per year (EUR 6.7 billion to
EUR 8.5 billion), with estimates in 2007, that each pressure ulcer
addsUSD43,180 (EUR31,580) in costs to a hospital stay (Agency
for Healthcare Research and Quality 2011). Within the acute care
setting in Australia in 2005, median opportunity costs for pressure
ulcers were estimated at AUD 285 million (EUR 202 million)
(Graves 2005). The human and economic drain on healthcare
systems is compounded by the fact that healthcare professionals
and clinicians are often not trained in prevention and treatment of
pressure ulcers, or remain in systems where multidisciplinary and
integrated care processes are not in place, or both (Moore 2013a).
Indeed, a higher incidence and prevalence of pressure ulcers has
been noted in settings where there are poor organisational strate-
gies for preventing and managing pressure ulcers (Igarashi 2013).
Description of the intervention
Since the late 1990s there have been reports of the impact that
multidisciplinary wound care teams can have on pressure ulcer
prevention and management in clinical practice (Doan-Johnson
1998; Dolynchuk 2000; Granick 1998). During this era, it was
noted that there was an increasing number of formal and infor-
mal multidisciplinary wound care teams that adhered to specific
patient-care protocols (Doan-Johnson 1998).
Once the best available evidence on the most appropriate way
to improve patients’ wound-related outcomes had been synthe-
sised and integrated with expert opinion, multidisciplinary wound
care teams were created in many settings through the consen-
sus of healthcare professionals with an interest in wound care
(Dolynchuk 2000; Gottrup 2003; Haworth 2009). Thus, multi-
disciplinary wound care teams were created to focus on delivering
high quality, holistic and patient-specific skin care to improve pa-
tients’ wound-related outcomes and to prevent the deterioration of
the integrity of patients’ tissue (Dolynchuk 2000; Gottrup 2003;
Haworth 2009).
The exact composition of the multidisciplinary wound care team
is mainly determined by the patient’s needs, thus, potentially, any
healthcare professional can be a member if it is in the patient’s best
interest (Gottrup 2004; Clark 2007; Zulkowski 2007; Haworth
2009). It is evident, therefore, that multidisciplinary wound care
teams can consist of different healthcare professionals. Teams’ key
roles include overseeing the pressure ulcer-related education of
staff, patients and carers; undertaking pressure ulcer-related re-
search; and supervising the patient’s pressure ulcer prevention and
management strategies (Dolynchuk 2000; Gottrup 2004; Ryan
2003; Woo 2008).
While a number of different approaches to the formation of multi-
disciplinary wound care teams have been reported in clinical prac-
tice, they are all said to have had a positive impact on the wound
prevention and management care that patients receive (Gottrup
2003; Gottrup 2004; Haworth 2009). Indeed, in one hospital,
the multidisciplinary wound care team was found to have reduced
the prevalence of pressure ulcers by 18% over three years, and in
a different hospital the team was reported to have reduced the
pressure ulcer prevalence by 15% in one year (Granick 1998). In
another setting, the multidisciplinary wound care team was re-
ported to achieve a high rate of wound healing as 68% of 103 pa-
tients with chronic wounds achieved complete or almost complete
wound healing, and only 2% of the patients had the recurrence of
an old wound (Donnelly 2000). However, the studies referred to
here lack the rigor required to clearly determine the impact of the
introduction of the multidisciplinary wound care team, because
they use a pre-post test design with significant time gaps between
the pre and post test, and outcome data were collected using an
audit methodology.
How the intervention might work
The intervention in this review is the wound care team: this review
will consider the impact that these teams have on pressure ulcer
prevention and management. We define the wound care team as
a formally-constituted team of healthcare professionals who work
closely to supervise the pressure ulcer prevention and manage-
ment care of people in hospitals or the community-care setting,
or both. The team may be multidisciplinary (e.g. any combina-
tion of dietician, nurse, medical doctor, physiotherapist, occupa-
tional therapist) or uni-disciplinary (e.g. team composed entirely
of nurses). The team may focus on a simple strategy (e.g. a turn-
ing only regime) or a complex strategy (e.g. dietary, mobilisation,
education).
The World Health Organisation (WHO) argues that collabora-
tive practice strengthens healthcare systems and improves health
outcomes (WHO 2010). Furthermore, WHO suggests that such
an approach to care delivery is key to optimising individual pa-
tient outcomes (WHO 2010), thereby enhancing overall health
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and social gain. Indeed, a lack of integrated care systems and
functioning multidisciplinary teams compounds the suffering of
patients and increases demands on already overstretched health
budgets (Moore 2005). Conversely, structured multidisciplinary
interventions, such as interdisciplinary collaboration and educa-
tion, improve patient outcomes and overall health service delivery
(Apelqvist 2000).
The multidisciplinary wound care team is expected to deliver bet-
ter outcomes compared to the alternative, where a patient’s pres-
sure ulcer prevention and management-related care is delivered
by one group of healthcare professionals, without the insight, ex-
pertise and active participation of fellow healthcare professionals.
There are a number of factors that can contribute to the forma-
tion of pressure ulcers, or can affect the healing of pressure ulcers,
which are perhaps best addressed by pooling the expertise of dif-
ferent healthcare professionals in order to enhance patient pres-
sure ulcer prevention and management-related outcomes. Thus,
themultidisciplinary wound care teammay have a positive impact
on these outcomes because it brings together a range of healthcare
professionals with different expertise in order to plan and deliver
care to prevent and manage pressure ulcers in a holistic way that
is designed to suit the patient’s individual needs.
Why it is important to do this review
International guidelines suggest that to prevent and manage pres-
sure ulcers successfully a team approach is required (Agency for
Healthcare Research and Quality 2011; EPUAP/NPUAP 2009).
Furthermore, a team approach to care delivery is advocated by
WHO (WHO 2010). Although there have been many reports
about the positive impact that wound care teams have had on
pressure ulcer prevention and management, many of these reports
appear to have been underpinned by anecdotal evidence, or have
been subjected to little critical scrutiny, so overall, the precise im-
pact of wound care teams is unclear. Therefore, it is important to
search and appraise the literature systematically in order to deter-
mine the impact of teams on the prevention and management of
pressure ulcers. The outcomes of this review will provide clinical
decision-makers with the evidence they need to determine whether
investment in such teams is of value.
O B J E C T I V E S
To assess the impact of wound care teams on preventing and treat-
ing pressure ulcers in people of any age, nursed in any setting.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We will include randomised controlled trials (RCTs) that evalu-
ate the effect of any configuration of wound care teams in the
treatment or prevention of pressure ulcers. For this intervention,
there is a high probability that hospitals, or wards within hospi-
tals, rather than individuals, will be randomised. Consequently,
we will also include cluster-randomised trials if the cluster design
has been properly accounted for in the trial’s analysis. We will also
consider including cluster-RCTs if information is available in the
paper, or from the investigator, that would allow us to conduct
an appropriate analysis. We will exclude trials that do not use a
validated instrument (such as the EPUAP/NPUAP 2009 defini-
tions) to assess pressure ulcers. We will also exclude studies using
quasi-randomisation, cross-over studies, controlled before-and-af-
ter studies and interrupted-time-series studies.
Types of participants
People of any age, in any setting (hospitals, nursing homes, resi-
dential care, rehabilitation centres) who are at risk of developing
a pressure ulcer (as identified through either a structured or un-
structured risk assessment, or by clinical judgement alone), or who
have an existing pressure ulcer (of any stage), will be eligible for
inclusion.
Types of interventions
The intervention of interest is a team that focuses on pressure ulcer
prevention, or treatment, or both. The team may be multidisci-
plinary (e.g. any combination of dietician, nurse, medical doctor,
physiotherapist, occupational therapist) or uni-disciplinary (e.g.
team composed entirely of nurses). The team may focus on a sim-
ple strategy (e.g. a turning only regime) or a complex strategy (e.g.
dietary, mobilisation, education).
The impact of the wound care team on pressure ulcer prevention
and management will be compared against the delivery of care
to prevent or manage pressure ulcers by an individual healthcare
professional.
Types of outcome measures
Primary and secondary outcomes will be considered under two
categories, prevention and treatment.
Primary outcomes
Prevention studies
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• Pressure ulcer incidence (the proportion of participants
developing any new pressure ulcer(s) of any grade).
Treatment studies
The primary outcome for treatment studies is complete healing,
but this may be measured and reported in several ways by trial
authors. We will include RCTs that report any of the following:
• an objective measure of pressure ulcer healing such as
absolute or percentage change in pressure ulcer area or volume
over time; proportion of individuals with pressure ulcers healed
at the completion of the trial period; or healing rate (we will
accept trials with any length of follow-up, we will adjust for any
differences in our analyses);
• time to complete wound healing (using methods of survival
analysis and expressing the intervention effect as a hazard ratio).
Secondary outcomes
Prevention studies
• Resource use (including costs associated with the team and
those costs associated with dressings and other additional
interventions where reported).
• Length of hospital stay.
• Satisfaction (using any validated scale).
• Morbidity (e.g. infection).
Treatment studies
• Pain (measured at any time with any validated instrument
e.g. Visual Analogue Scale).
• All-cause mortality.
• Health-related quality of life (using any validated measure
such WHOQOL-BREF, SF-36, SF-12).
• Cost (including resources associated with the team and
those associated with dressings and other additional
interventions where reported).
• Morbidity (e.g. infection, proportion requiring surgical
repair).
• Mortality (pressure ulcer- or infection-related mortality).
Search methods for identification of studies
Wewill search the following electronic databases to identify reports
of relevant randomised clinical trials or cluster-RCTs that evaluate
the use of wound care teams for the prevention or treatment of
pressure ulcers.
Electronic searches
We will search the following databases:
• The Cochrane Wounds Group Specialised Register;
• The Cochrane Central Register of Controlled Trials
(CENTRAL) (The Cochrane Library) (latest issue);
• Ovid MEDLINE (1946 to present);
• Ovid EMBASE (1974 to present);
• EBSCO CINAHL (1982 to present).
We will use the following strategy for CENTRAL:
#1 MeSH descriptor: [Patient Care Team] explode all trees
#2 ((care or health or healthcare or medical or nursing or interdis-
ciplinary or multidisciplinary or wound* or turn*) next team*):
ti,ab,kw
#3 (“team nursing” or nurse-led or nurse-centred):ti,ab,kw
#4 {or #1-#3}
#5 MeSH descriptor: [Pressure Ulcer] explode all trees
#6 (pressure next (ulcer* or sore* or injur*)):ti,ab,kw
#7 (decubitus next (ulcer* or sore*)):ti,ab,kw
#8 ((bed next sore*) or bedsore):ti,ab,kw
#9 {or #5-#8}
#10 #4 and #9
We will combine the Ovid MEDLINE search with the Cochrane
Highly Sensitive Search Strategy for identifying randomised tri-
als in MEDLINE: sensitivity- and precision-maximising version
(2008 revision) (Lefebvre 2011). We will combine the EM-
BASE search with the Ovid EMBASE filter developed by the UK
Cochrane Centre (Lefebvre 2011).We will combine theCINAHL
searches with the trial filters developed by the Scottish Intercolle-
giate Guidelines Network (SIGN 2013). There will be no restric-
tions with respect to language, date of publication or study setting.
We will also search the following clinical trials registries:
• ClinicalTrials.gov,
• WHO International Clinical Trials Registry (ICTR),
• The EU Clinical Trials Register (https://
www.clinicaltrialsregister.eu/).
Searching other resources
We will search reference lists of all included studies and other
relevant publications, such as systematic reviews and guidelines.
We will contact experts in the field and the authors of relevant
publications to identify any completed or ongoing trials. We will
also performmanual searches of conference proceedings to identify
authors and papers related primarily to wound care teams for the
prevention, or treatment, or both, of pressure ulcers.
Data collection and analysis
We will perform the systematic review according to instructions
in the Cochrane Handbook for Systematic Reviews of Interventions
(Green 2011).
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Selection of studies
Two review authors will independently screen all titles and ab-
stracts retrieved by the searches, and exclude those that clearly do
not meet the inclusion criteria. We will obtain full texts of the
remaining papers and they will be assessed by two review authors
for eligibility. Any disagreement will be resolved by discussion be-
tween all review authors or, if consensus cannot be reached, by
referral to the editorial base of the Cochrane Wounds Group.
Data extraction and management
Two review authors will independently extract data from eligible
studies using a data extraction sheet developed for this purpose.
Specifically, we will extract the following information:
• author, title, source;
• date of study, country of origin;
• care setting;
• inclusion and exclusion criteria;
• baseline participant characteristics;
• sample size calculation;
• number of participants randomised to each arm;
• study design details;
• trial quality (method of randomisation; allocation
concealment; blinding of the participant and outcome assessor;
completeness of reporting);
• intervention details (specifically team composition and
focus of the intervention), concurrent intervention(s);
• primary and secondary outcomes (with definitions);
• length of follow-up;
• loss to follow-up;
• outcomes data for primary and secondary outcomes (by
group);
• intention-to-treat analysis;
• funding source;
• conflicts of interest.
Any differences in opinion will be resolved by discussion and,
where necessary, with reference to the Cochrane Wounds Group
editorial base. If data are missing from reports, we will attempt to
contact study authors to obtain the missing information. We will
include multiple reports of the same study to extract the maximal
amount of information, ensuring that data are not duplicated.One
review author will enter data into Review Manager 5.2 software
(RevMan 2011), with a second author verifying accuracy.
Assessment of risk of bias in included studies
Independently, two review authors will assess the included stud-
ies using the Cochrane Collaboration tool for assessing risk of
bias (Higgins 2011a). This tool addresses six specific domains,
namely: sequence generation, allocation concealment, blinding,
incomplete outcome data, selective outcome reporting and other
issues (e.g. extreme baseline imbalance). Appendix 1 contains de-
tails of the criteria on which this assessment will be based. We will
assess blinding and completeness of outcome data for each out-
come separately (for example, blinding is important for subjective
outcomes such as pressure ulcer healing and pain). We will present
our assessment of risk of bias using two ’Risk of bias’ summary fig-
ures; one will be a summary of bias for each item across all studies,
and the second will show a cross-tabulation of each trial by all of
the risk of bias items. For trials using cluster randomisation, we
will assess the risk of bias using the following domains: recruit-
ment bias, baseline imbalance, loss of clusters, incorrect analysis
and comparability with individually randomised trials (Higgins
2011b).
Measures of treatment effect
For dichotomous outcomes (e.g. proportion with a pressure ulcer)
the risk ratio (RR)will be calculatedwith 95%confidence intervals
(CI). For continuously distributed outcome data (e.g. pain) we
will use the mean difference (MD) with 95% CIs, if all trials use
the same assessment scale. If trials use different assessment scales,
we will use the standardised mean difference (SMD)with 95%CI.
Time-to-event data (e.g. time to complete wound healing), will be
reported as hazard ratios (HR) where possible, in accordance with
the methods described in the Cochrane Handbook for Systematic
Reviews of Interventions (Deeks 2011). For statistically significant
effects in binary outcomes, number needed to treat to benefit
(NNTB), or number needed to harm (NNH), will be calculated.
If skewness is suspected, and if scale data have finite upper and
lower limits, we will use the easy ’rule of thumb’ calculation to
test for skewness. That is, if the standard deviation (SD), when
doubled, is greater than the mean, it is unlikely that the mean is
the centre of the distribution (Altman 1996), and wewill not enter
the data into any meta-analysis. If we find relevant data that are
skewed, we will present the data in ’Other data’ tables.
Summary of findings
To assess the overall body of evidence, we will develop a summary
of findings table using GRADE profilerT M . The quality of the
body of evidence will be assessed against five principle domains:
1) limitations in design and implementation; 2) indirectness of
evidence or generalisability of findings; 3) inconsistency of results -
for example unexplained heterogeneity and inconsistent findings;
4) imprecision of results where confidence intervals are wide; and
5) other potential biases, for example publication bias or high
manufacturer involvement (Shunemann 2011).
Unit of analysis issues
We will check unit of analysis issues if cluster RCTs are included.
If required, and if sufficient data are available, we will recalcu-
late results using the appropriate unit of analysis (Higgins 2011b).
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We will also note whether participants, or ulcers, have been ran-
domised. Where there is evidence that multiple ulcers on a sin-
gle person have been analysed incorrectly (that is, by considering
outcomes for multiple ulcers as independent), we will seek further
information from the trialist. For cluster trials that have used anal-
ysis methods to account for the clustering, we will extract effect
sizes and standard errors from the appropriate analysis.
Dealing with missing data
Where possible, we will perform all analyses using the intention-
to-treat (ITT) principle, that is, participants will be analysed ac-
cording to their allocated treatment group. Where it appears that
data have been excluded from the analyses, we will contact authors
for these missing data. If data remain missing, despite our best
efforts to obtain them, we will assume that those missing from
the analysis of dichotomous data had a negative outcome (e.g. de-
veloped a pressure ulcer or did not completely heal). For contin-
uous data, if standard deviations are missing, where possible, we
will compute them from standard errors (SE) using the formula
SD = SE x
√
N (Higgins 2011c). If this is not possible, we will
impute SDs from similar continuous outcome data and use sen-
sitivity analyses to assess the impact of the assumptions we make
(i.e. using small or large SDs) (Higgins 2011b). Where results are
reported for all participants, but it is unclear how many people
were originally randomised, we will use an available-case analysis.
Assessment of heterogeneity
Clinical heterogeneity will be assessed in terms of how comparable
trials are according to their inclusion criteria, intervention and
outcome measures. Statistical heterogeneity will be assessed by
visual inspection of forest plots, by the Chi2 test with significance
set at 0.10, and by the I2 statistic, which examines the percentage
of total variation across studies that is due to heterogeneity rather
than chance (Higgins 2003). Where I2 values are 40% or less, we
will consider heterogeneity to be low, and where I2 values exceed
75% we will consider it to be high.
Assessment of reporting biases
Reporting bias will be assessed using guidelines in the Cochrane
Handbook for Systematic Reveiws of Interventions (Stern 2011). If
enough studies are available for a meaningful assessment of publi-
cation bias, a funnel plot of primary outcomes will be constructed
to test for asymmetry. We will also consider selective reporting
(i.e. reporting some outcomes and not others) in our assessment
of reporting bias.
Data synthesis
Initially we will present a structured narrative summary of the
studies reviewed. Quantitative data will be entered into Review
Manager for analysis (RevMan 2011). If included studies are suf-
ficiently similar in terms of population, inclusion criteria, inter-
ventions and outcomes (including the times at which outcomes
are assessed in both intervention and treatment trials) we will con-
sider pooling the data statistically, using meta-analysis. We will use
a fixed-effect model if appropriate (i.e. when I2 values are 40%
or less), otherwise we will use a random effects model. We will
not pool data where the I2 values are greater than 75%. A sum-
mary of results from the data synthesis and assessment of quality
of evidence will be included in a ’Summary of findings’ table for
the main comparisons. Cluster trials will be combined with indi-
vidually randomised trials in the same meta-analysis, using sub-
groups to assess the affect of the randomisation method. We will
explore the possibility of important differences in the effects being
evaluated in the different types of trials before conducting meta-
analysis (Higgins 2011b). We will include trials that report time
to event data as continuous, using means or medians, but results
from these trials will be reported in the narrative and will not be
included in any meta-analyses.
Subgroup analysis and investigation of heterogeneity
If substantial heterogeneity exists between studies for the primary
outcomes (that is, when the I2 statistic exceeds 50%) ,we will
explore reasons for heterogeneity. We envisage that the number of
studies meeting our inclusion criteria may be low. Consequently,
to avoid type 1 errors we plan to conduct a minimal number of
sub-analyses that will include the following, if possible:
• acute care versus residential care;
• type of wound care team (e.g. single discipline versus multi-
disciplinary);
• type of intervention (single-factor versus multi-factorial).
Sensitivity analysis
Will will perform a sensitivity analysis by excluding those studies
assessed as having a high risk of bias in the key domains of ’gener-
ating the randomisation sequence’, ’allocation concealment’ and
’blinding of outcome assessment’. We will also explore the effect
of unpublished studies, small studies (less than 100 participants)
and cluster trials, where the analysis was not at the same level as the
allocation (i.e. allocation by cluster and analysis by individual).
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A P P E N D I C E S
Appendix 1. Risk of bias criteria
1. Was the allocation sequence randomly generated?
Low risk of bias
The investigators describe a random component in the sequence generation process such as: referring to a random number table; using
a computer random-number generator; coin tossing; shuffling cards or envelopes; throwing dice; drawing of lots.
High risk of bias
The investigators describe a non-random component in the sequence generation process. Usually, the description would involve some
systematic, non-random approach, for example: sequence generated by odd or even date of birth; sequence generated by some rule
based on date (or day) of admission; sequence generated by some rule based on hospital or clinic record number.
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Unclear
Insufficient information about the sequence generation process to permit judgement of low or high risk of bias to be made.
2. Was the treatment allocation adequately concealed?
Low risk of bias
Participants and investigators enrolling participants could not foresee assignment because one of the following, or an equivalent
method, was used to conceal allocation: central allocation (including telephone, web-based and pharmacy-controlled randomisation);
sequentially-numbered drug containers of identical appearance; sequentially-numbered, opaque, sealed envelopes.
High risk of bias
Participants or investigators enrolling participants could possibly foresee assignments and thus introduce selection bias, such as allocation
based on: using an open random allocation schedule (e.g. a list of randomnumbers); assignment envelopes were usedwithout appropriate
safeguards (e.g. if envelopes were unsealed or nonopaque or not sequentially numbered); alternation or rotation; date of birth; case
record number; any other explicitly unconcealed procedure.
Unclear
Insufficient information available to permit judgement of low or high risk of bias to be made. This is usually the case if the method of
concealment is not described, or not described in sufficient detail to allow a definite judgement, for example if the use of assignment
envelopes is described, but it remains unclear whether envelopes were sequentially numbered, opaque and sealed.
3. Blinding - was knowledge of the allocated interventions adequately prevented during the study?
Low risk of bias
Any one of the following.
• No blinding, but the review authors judge that the outcome and the outcome measurement are not likely to be influenced by
lack of blinding.
• Blinding of participants and key study personnel ensured, and unlikely that the blinding could have been broken.
• Either participants or some key study personnel were not blinded, but outcome assessment was blinded and the non-blinding of
others was unlikely to introduce bias.
High risk of bias
Any one of the following.
• No blinding or incomplete blinding, and the outcome or outcome measurement was likely to be influenced by lack of blinding.
• Blinding of key study participants and personnel attempted, but likely that the blinding could have been broken.
• Either participants or some key study personnel were not blinded, and the non-blinding of others was likely to introduce bias.
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Unclear
Either of the following.
• Insufficient information available to permit judgement of low or high risk of bias to be made.
• The study did not address this outcome.
4. Were incomplete outcome data adequately addressed?
Low risk of bias
Any one of the following.
• No missing outcome data.
• Reasons for missing outcome data were unlikely to be related to true outcome (for survival data, censoring unlikely to be
introducing bias).
• Missing outcome data are balanced in numbers across intervention groups, with similar reasons for missing data across groups.
• For dichotomous outcome data, the proportion of missing outcomes compared with observed event risk is not enough to have a
clinically relevant impact on the intervention effect estimate.
• For continuous outcome data, plausible effect size (difference in means or standardised difference in means) among missing
outcomes is not enough to have a clinically relevant impact on observed effect size.
• Missing data have been imputed using appropriate methods.
High risk of bias
Any one of the following.
• Reason for missing outcome data likely to be related to true outcome, with either imbalance in numbers or reasons for missing
data across intervention groups.
• For dichotomous outcome data, the proportion of missing outcomes compared with the observed event risk is enough to induce
clinically relevant bias in intervention effect estimate.
• For continuous outcome data, plausible effect size (difference in means or standardised difference in means) among missing
outcomes is enough to induce clinically relevant bias in observed effect size.
• ‘As-treated’ analysis done with substantial departure in the intervention received from that assigned at randomisation.
• Potentially inappropriate application of simple imputation.
Unclear
Either of the following.
• Insufficient reporting of attrition/exclusions to permit judgement of low or high risk of bias (e.g. number randomised not stated,
no reasons for missing data provided).
• The study did not address this outcome.
5. Are reports of the study free of suggestion of selective outcome reporting?
Low risk of bias
Either of the following.
• The study protocol is available and all of the study’s pre-specified (primary and secondary) outcomes that are of interest in the
review have been reported in the pre-specified way.
• The study protocol is not available but it is clear that the published reports include all expected outcomes, including those that
were pre-specified (convincing text of this nature may be uncommon).
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High risk of bias
Any one of the following.
• Not all of the study’s pre-specified primary outcomes have been reported.
• One or more primary outcomes is reported using measurements, analysis methods or subsets of the data (e.g. sub scales) that
were not pre-specified.
• One or more of the reported primary outcomes was not pre-specified (unless clear justification for their reporting is provided,
such as an unexpected adverse effect).
• One or more outcomes of interest in the review are reported incompletely so that they cannot be entered in a meta-analysis.
• The study report fails to include results for a key outcome that would be expected to have been reported for such a study.
Unclear
Insufficient information is available to permit a judgement of low or high risk of bias to be made. It is likely that the majority of studies
will fall into this category.
6. Other sources of potential bias
Low risk of bias
The study appears to be free of other sources of bias.
High risk of bias
There is at least one important risk of bias. For example, the study:
• had a potential source of bias related to the specific study design used; or
• had extreme baseline imbalance; or
• has been claimed to have been fraudulent; or
• had some other problem.
Unclear
There may be a risk of bias, but there is either:
• insufficient information to assess whether an important risk of bias exists; or
• insufficient rationale or evidence that an identified problem will introduce bias.
WH A T ’ S N E W
Date Event Description
24 February 2015 Amended Contact details updated.
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